Clene to Present at Upcoming September Investor Conferences
Stocks in this Quantisnow insightHealth Care
Historical context for CLNN
Across the 18 sessions after earlier CLNN headlines, the stock closed higher 9 times and lower 9 times, with a median move of 6.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CLNN | SPY |
|---|---|---|---|
| Aug 17, 2026 | Clene to Present at the Emerging Growth Conference | +1.4% | -0.5% |
| Aug 14, 2026 | Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights | -1.2% | -0.2% |
| Aug 10, 2026 | Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval | -2.3% | -0.0% |
| Jul 29, 2026 | Clene to Present at The Canaccord 46th Annual Growth Conference | -5.4% | -1.5% |
| May 14, 2026 | Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights | +8.5% | +0.8% |
| May 5, 2026 | Clene Announces $7 Million Underwritten Offering of Common Stockand 1 other headline that session | -18.7% | +0.8% |
Quantisnow market dataNASDAQ
CLNN
Clene Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for CLNN
Full CLNN profile on Quantisnow Follow CLNN and get a push notification the moment its next story breaks.